English Korean Chinese
ホーム > 市場調査レポート > バイオテクノロジー > ゲノム創薬 > 欧州のテラノスティクス市場の戦略的分析
カテゴリ
バイオテクノロジー (1630)
オーダーメイド医療 (51)
ゲノム創薬 (203)
バイオマーカー (158)
バイオマテリアル (54)
バイオ機器 (385)
遺伝子療法/RNAi (103)
抗体/免疫 (194)
再生医療 (122)
分子標的療法 (132)
市場調査レポート

欧州のテラノスティクス市場の戦略的分析

Strategic Analysis of the European Markets for Theranostics

発行 Frost & Sullivan
出版日 2009年05月 商品コード 89718
ページ情報 英文 53 Pages
価格
US$ 6,500 換算 ¥ 523,055 (税抜) Web Access (Regional License)
US$ 7,000 換算 ¥ 563,290 (税抜) Hard Copy & Web Access (Regional License)


原文目次

Abstract

This strategic analysis service provides a detailed analysis of the European theranostics market. An indepth analysis of marketing parameters coupled with competitive factors and strategies for sustained market prevalence are reported.

Table of Contents

1. STRATEGIC ANALYSIS OF THE EUROPEAN MARKETS FOR THERANOSTICS

Overview

  • Overview

Research Scope and Methodology

  • Research Scope and Methodology

Background and Applications of Theranostics

  • Benefits of Theranostics
  • Test Categories
  • Stakeholder Analysis
  • Pharma-diagnostic Convergence
  • Opportunities
  • Role in Pharmaceutical Industry
  • Application in Drug Development Process

Key Industry Challenges and Recommendations

  • Industry Challenges

Key Market Dynamics: Drivers and Restraints

  • Drivers and Restraints

Key Disease Areas:Role of Theranostics

  • Disease Areas

Special Focus:Oncology

  • Oncology
  • Recent Advances in Cancer Theranostics

Competitive Overview

  • Competitive Overview
  • Drugs with Companion Tests

Regulatory Scenario : FDA and EMEA Perspective

  • Regulatory Scenario

SWOT Analysis

  • SWOT Analysis

Conclusion

  • Conclusion

Decision Support Database

  • Decision Support Database

Key Industry Participants

  • Key Industry Participants
Back to Top